Ledger.Open graph →
SEC Form D · Amendment · filed July 21, 2025

Durin Life Sciences, Inc

Offering
$10.0M
Sold
$6.2M
Exemption
Rule 506(b)
Industry
Biotechnology
Location
STRATFORD, NJ
Type

Rule 506(b): private placement to accredited investors, no public advertising.

People & firms on this filing (8)

Robert Nagele · Stratford, NJDirectorRene Chaze · Stratford, NJDirectorRobert Nagele · Stratford, NJDirectorRene Chaze · Stratford, NJDirectorMaribeth Bluyus · Stratford, NJExecDenis G. Patrick · Boston, MADirectorNadine Miller · Toronto, Ontario, CanadaDirectorMaribeth Bluyus · Stratford, NJExec

Public SEC Form D (Reg D) filing. · View issuer on SEC EDGAR ↗